TABLE OF CONTENT 1 EXECUTIVE SUMMARY 2 MARKET INTRODUCTION 2.1 SCOPE OF THE STUDY 14 2.2 RESEARCH OBJECTIVE 14 2.3 LIST OF ASSUMPTIONS 14 3 RESEARCH METHODOLOGY 3.1 OVERVIEW 16 3.2 DATA MINING 16 3.3 SECONDARY RESEARCH 17 3.4 PRIMARY RESEARCH 17 3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 18 3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 19 3.5 FORECASTING TECHNIQUES 19 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 20 3.6.1 BOTTOM-UP APPROACH 21 3.6.2 TOP-DOWN APPROACH 22 3.7 DATA TRIANGULATION 23 3.8 VALIDATION 23 4 MARKET DYNAMICS 4.1 OVERVIEW 24 4.2 DRIVERS 25 4.2.1 INCREASING STRATEGIC AGREEMENTS 25 4.2.2 INCREASING PUBLIC AND PRIVATE INITIATIVES FOR RESEARCH AND DEVELOPMENT 25 4.3 RESTRAINTS 26 4.3.1 UNAFFORDABILITY OF PROVIDING VETERINARY SERVICES IN UNDEVELOPED AND DEVELOPING ECONOMIES 26 4.4 OPPORTUNITIES 27 4.4.1 INCREASING NUMBER OF CLINICAL TRIAL CANDIDATES 27 5 MARKET FACTOR ANALYSIS 5.1 SUPPLY CHAIN ANALYSIS 28 5.1.1 R&D & DESIGNING 29 5.1.2 MANUFACTURING 29 5.1.3 DISTRIBUTION, MARKETING, AND SALES 29 5.2 PORTER’S FIVE FORCES MODEL 30 5.2.1 THREAT OF NEW ENTRANTS 30 5.2.2 BARGAINING POWER OF SUPPLIERS 31 5.2.3 BARGAINING POWER OF BUYERS 31 5.2.4 THREAT OF SUBSTITUTES 31 5.2.5 INTENSITY OF RIVALRY 31 6 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY STRAIN 6.1 OVERVIEW 32 6.2 H5 33 6.3 H7 34 6.4 H9 34 7 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION 7.1 OVERVIEW 35 7.2 CHICKEN 36 7.3 TURKEY 37 7.4 GOOSE & DUCK 37 8 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY REGION 8.1 OVERVIEW 39 8.2 APAC & MIDDLE EAST 41 8.2.1 CHINA 43 8.2.2 PHILIPPINES 44 8.2.3 VIETNAM 44 8.2.4 INDIA 45 8.2.5 BANGLADESH 46 8.2.6 CAMBODIA 46 8.2.7 INDONESIA 47 8.2.8 IRAN 48 8.2.9 THAILAND 48 8.2.10 PAKISTAN 49 8.2.11 REST OF APAC & MIDDLE EAST 50 8.3 EUROPE 51 8.3.1 GERMANY 53 8.3.2 BULGARIA 53 8.3.3 POLAND 54 8.3.4 HUNGARY 55 8.3.5 UKRAINE 55 8.3.6 CZECH REPUBLIC 56 8.3.7 REST OF EUROPE 57 8.4 AMERICAS 58 8.4.1 US 60 8.4.2 BRAZIL 60 8.4.3 MEXICO 61 8.4.4 ARGENTINA 62 8.4.5 COLUMBIA 62 8.4.6 REST OF THE AMERICAS 63 8.5 AFRICA 64 8.5.1 SOUTH AFRICA 65 8.5.2 NIGERIA 66 8.5.3 GHANA 67 8.5.4 CAMEROON 67 8.5.5 REST OF AFRICA 68 9 COMPETITIVE LANDSCAPE 9.1 OVERVIEW 69 9.2 COMPETITIVE ANALYSIS 69 10 COMPANY PROFILES 10.1 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 70 10.1.1 COMPANY OVERVIEW 70 10.1.2 FINANCIAL OVERVIEW 71 10.1.3 PRODUCTS/SERVICES OFFERED 71 10.1.4 KEY DEVELOPMENTS 72 10.2 GUANGDONG WENSHI DAHUANONG BIOTECHNOLOGY CO., LTD 73 10.2.1 COMPANY OVERVIEW 73 10.2.2 FINANCIAL OVERVIEW 73 10.2.3 PRODUCTS/SERVICES OFFERED 73 10.2.4 KEY DEVELOPMENTS 73 10.3 CEVA 74 10.3.1 COMPANY OVERVIEW 74 10.3.2 FINANCIAL OVERVIEW 74 10.3.3 PRODUCTS/SERVICES OFFERED 75 10.3.4 KEY DEVELOPMENTS 75 10.4 YEBIO BIOENGINEERING CO., LTD 76 10.4.1 COMPANY OVERVIEW 76 10.4.2 FINANCIAL OVERVIEW 76 10.4.3 PRODUCTS/SERVICES OFFERED 76 10.4.4 KEY DEVELOPMENTS 76 10.5 ZOETIS 77 10.5.1 COMPANY OVERVIEW 77 10.5.2 FINANCIAL OVERVIEW 77 10.5.3 PRODUCTS/SERVICES OFFERED 78 10.5.4 KEY DEVELOPMENTS 78 10.6 FATRO S.P.A. 79 10.6.1 COMPANY OVERVIEW 79 10.6.2 FINANCIAL OVERVIEW 79 10.6.3 PRODUCTS/SERVICES OFFERED 79 10.6.4 KEY DEVELOPMENTS 79 10.7 CAVAC 80 10.7.1 COMPANY OVERVIEW 80 10.7.2 FINANCIAL OVERVIEW 80 10.7.3 PRODUCTS/SERVICES OFFERED 80 10.7.4 KEY DEVELOPMENTS 80 10.8 TIANJIN RINGPU BIO-TECHNOLOGY CO., LTD 81 10.8.1 COMPANY OVERVIEW 81 10.8.2 FINANCIAL OVERVIEW 81 10.8.3 PRODUCTS/SERVICES OFFERED 81 10.8.4 KEY DEVELOPMENTS 81 10.9 PT JAPFA COMFEED INDONESIA TBK 82 10.9.1 COMPANY OVERVIEW 82 10.9.2 FINANCIAL OVERVIEW 82 10.9.3 PRODUCTS/SERVICES OFFERED 83 10.9.4 KEY DEVELOPMENTS 83 10.10 CHENGDU TECH-BANK BIOLOGICAL PRODUCTS CO., LTD 84 10.10.1 COMPANY OVERVIEW 84 10.10.2 FINANCIAL OVERVIEW 84 10.10.3 PRODUCTS/SERVICES OFFERED 84 10.10.4 KEY DEVELOPMENTS 84 10.11 MERCK ANIMAL HEALTH 85 10.11.1 COMPANY OVERVIEW 85 10.11.2 FINANCIAL OVERVIEW 85 10.11.3 PRODUCTS/SERVICES OFFERED 86 10.11.4 KEY DEVELOPMENTS 86 10.12 MEDION 87 10.12.1 COMPANY OVERVIEW 87 10.12.2 FINANCIAL OVERVIEW 87 10.12.3 PRODUCTS/SERVICES OFFERED 87 10.12.4 KEY DEVELOPMENTS 87 10.13 AVIMEX ANIMAL HEALTH 88 10.13.1 COMPANY OVERVIEW 88 10.13.2 FINANCIAL OVERVIEW 88 10.13.3 PRODUCTS/SERVICES OFFERED 88 10.13.4 KEY DEVELOPMENTS 88 10.14 JOVAC 89 10.14.1 COMPANY OVERVIEW 89 10.14.2 FINANCIAL OVERVIEW 89 10.14.3 PRODUCTS/SERVICES OFFERED 89 10.14.4 KEY DEVELOPMENTS 89 10.15 QYH BIOTECH COMPANY LIMITED 90 10.15.1 COMPANY OVERVIEW 90 10.15.2 FINANCIAL OVERVIEW 90 10.15.3 PRODUCTS/SERVICES OFFERED 90 10.15.4 KEY DEVELOPMENTS 90 11 APPENDIX 11.1 REFERENCES 91 11.2 RELATED REPORTS 91

LIST OF TABLES TABLE 1 LIST OF ASSUMPTIONS 14 TABLE 2 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 32 TABLE 3 GLOBAL AVIAN INFLUENZA VACCINE MARKET, FOR H5, BY REGION, 2016–2025 (USD MILLION) 33 TABLE 4 GLOBAL AVIAN INFLUENZA VACCINE MARKET, FOR H7, BY REGION, 2016–2025 (USD MILLION) 34 TABLE 5 GLOBAL AVIAN INFLUENZA VACCINE MARKET, FOR H9, BY REGION, 2016–2025 (USD MILLION) 34 TABLE 6 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 35 TABLE 7 GLOBAL AVIAN INFLUENZA VACCINE MARKET, FOR CHICKEN, BY REGION, 2016–2025 (USD MILLION) 36 TABLE 8 GLOBAL AVIAN INFLUENZA VACCINE MARKET, FOR TURKEY, BY REGION, 2016–2025 (USD MILLION) 37 TABLE 9 GLOBAL AVIAN INFLUENZA VACCINE MARKET, FOR GOOSE, BY REGION, 2016–2025 (USD MILLION) 38 TABLE 10 GLOBAL AVIAN INFLUENZA VACCINE MARKET, FOR DUCK, BY REGION, 2016–2025 (USD MILLION) 38 TABLE 11 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY REGION, 2016–2025 (USD MILLION) 39 TABLE 12 APAC & MIDDLE EAST: AVIAN INFLUENZA VACCINE MARKET, BY COUNTRY, 2016–2025 (USD MILLION) 42 TABLE 13 APAC & MIDDLE EAST: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 42 TABLE 14 APAC & MIDDLE EAST: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 43 TABLE 15 CHINA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 43 TABLE 16 CHINA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 43 TABLE 17 PHILIPPINES: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 44 TABLE 18 PHILIPPINES: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 44 TABLE 19 VIETNAM: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 44 TABLE 20 VIETNAM: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 45 TABLE 21 INDIA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 45 TABLE 22 INDIA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 45 TABLE 23 BANGLADESH: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 46 TABLE 24 BANGLADESH: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 46 TABLE 25 CAMBODIA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 46 TABLE 26 CAMBODIA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 47 TABLE 27 INDONESIA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 47 TABLE 28 INDONESIA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 47 TABLE 29 IRAN: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 48 TABLE 30 IRAN: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 48 TABLE 31 THAILAND: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 48 TABLE 32 THAILAND: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 49 TABLE 33 PAKISTAN: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 49 TABLE 34 PAKISTAN: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 49 TABLE 35 REST OF APAC & MIDDLE EAST: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 50 TABLE 36 REST OF APAC & MIDDLE EAST: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 50 TABLE 37 EUROPE: AVIAN INFLUENZA VACCINE MARKET, BY COUNTRY, 2016–2025 (USD MILLION) 52 TABLE 38 EUROPE: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 52 TABLE 39 EUROPE: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 52 TABLE 40 GERMANY: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 53 TABLE 41 GERMANY: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 53 TABLE 42 BULGARIA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 53 TABLE 43 BULGARIA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 54 TABLE 44 POLAND: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 54 TABLE 45 POLAND: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 54 TABLE 46 HUNGARY: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 55 TABLE 47 HUNGARY: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 55 TABLE 48 UKRAINE: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 55 TABLE 49 UKRAINE: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 56 TABLE 50 CZECH REPUBLIC: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 56 TABLE 51 CZECH REPUBLIC: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 56 TABLE 52 REST OF EUROPE: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 57 TABLE 53 REST OF EUROPE: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 57 TABLE 54 AMERICAS: AVIAN INFLUENZA VACCINE MARKET, BY COUNTRY, 2016–2025 (USD MILLION) 59 TABLE 55 AMERICAS: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 59 TABLE 56 AMERICAS: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 59 TABLE 57 US: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 60 TABLE 58 US: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 60 TABLE 59 BRAZIL: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 60 TABLE 60 BRAZIL: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 61 TABLE 61 MEXICO: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 61 TABLE 62 MEXICO: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 61 TABLE 63 ARGENTINA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 62 TABLE 64 ARGENTINA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 62 TABLE 65 COLUMBIA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 62 TABLE 66 COLUMBIA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 63 TABLE 67 REST OF THE AMERICAS: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 63 TABLE 68 REST OF THE AMERICAS: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 63 TABLE 69 AFRICA: AVIAN INFLUENZA VACCINE MARKET, BY COUNTRY, 2016–2025 (USD MILLION) 64 TABLE 70 AFRICA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 65 TABLE 71 AFRICA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 65 TABLE 72 SOUTH AFRICA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 65 TABLE 73 SOUTH AFRICA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 66 TABLE 74 NIGERIA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 66 TABLE 75 NIGERIA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 66 TABLE 76 GHANA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 67 TABLE 77 GHANA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 67 TABLE 78 CAMEROON: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 67 TABLE 79 CAMEROON: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 68 TABLE 80 REST OF AFRICA: AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2016–2025 (USD MILLION) 68 TABLE 81 REST OF AFRICA: AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2016–2025 (USD MILLION) 68 TABLE 82 MAJOR MANUFACTURERS: GLOBAL AVIAN INFLUENZA VACCINE MARKET 69 TABLE 83 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCTS/SERVICES OFFERED 71 TABLE 84 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: KEY DEVELOPMENTS 72 TABLE 85 GUANGDONG WENSHI DAHUANONG BIOTECHNOLOGY CO., LTD: PRODUCTS/SERVICES OFFERED 73 TABLE 86 CEVA: PRODUCTS/SERVICES OFFERED 75 TABLE 87 CEVA: KEY DEVELOPMENTS 75 TABLE 88 YEBIO BIOENGINEERING CO., LTD: PRODUCTS/SERVICES OFFERED 76 TABLE 89 ZOETIS: PRODUCTS/SERVICES OFFERED 78 TABLE 90 ZOETIS: KEY DEVELOPMENTS 78 TABLE 91 FATRO S.P.A.: PRODUCTS/SERVICES OFFERED 79 TABLE 92 CAVAC: PRODUCTS/SERVICES OFFERED 80 TABLE 93 TIANJIN RINGPU BIO-TECHNOLOGY CO., LTD: PRODUCTS/SERVICES OFFERED 81 TABLE 94 PT JAPFA COMFEED INDONESIA TBK: PRODUCTS/SERVICES OFFERED 83 TABLE 95 CHENGDU TECH-BANK BIOLOGICAL PRODUCTS CO., LTD: PRODUCTS/SERVICES OFFERED 84 TABLE 96 MERCK ANIMAL HEALTH: PRODUCTS/SERVICES OFFERED 86 TABLE 97 MERCK ANIMAL HEALTH: KEY DEVELOPMENTS 86 TABLE 98 MEDION: PRODUCTS/SERVICES OFFERED 87 TABLE 99 AVIMEX ANIMAL HEALTH: PRODUCTS/SERVICES OFFERED 88 TABLE 100 JOVAC: PRODUCTS/SERVICES OFFERED 89 TABLE 101 QYH BIOTECH COMPANY LIMITED: PRODUCTS/SERVICES OFFERED 90 LIST OF FIGURES FIGURE 1 MARKET SYNOPSIS 13 FIGURE 2 GLOBAL AVIAN INFLUENZA VACCINE MARKET STRUCTURE 15 FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 21 FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL AVIAN INFLUENZA VACCINE MARKET 24 FIGURE 5 DRIVER IMPACT ANALYSIS 26 FIGURE 6 RESTRAINT IMPACT ANALYSIS 26 FIGURE 7 SUPPLY CHAIN ANALYSIS 28 FIGURE 8 PORTER’S FIVE FORCES MODEL 30 FIGURE 9 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2018 (%) 32 FIGURE 10 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY STRAIN, 2018 & 2025 (USD MILLION) 33 FIGURE 11 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2018 (%) 35 FIGURE 12 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY APPLICATION, 2018 & 2025 (USD MILLION) 36 FIGURE 13 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY REGION, 2018 (%) 39 FIGURE 14 GLOBAL AVIAN INFLUENZA VACCINE MARKET, BY REGION, 2018 & 2025 (USD MILLION) 40 FIGURE 15 APAC & MIDDLE EAST: AVIAN INFLUENZA VACCINE MARKET, BY COUNTRY, 2018 (%) 41 FIGURE 16 EUROPE: AVIAN INFLUENZA VACCINE MARKET, BY COUNTRY, 2018 (%) 51 FIGURE 17 AMERICAS: AVIAN INFLUENZA VACCINE MARKET, BY COUNTRY, 2018 (%) 58 FIGURE 18 AFRICA: AVIAN INFLUENZA VACCINE MARKET, BY COUNTRY, 2018 (%) 64 FIGURE 19 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: FINANCIAL OVERVIEW SNAPSHOT 71 FIGURE 20 CEVA: FINANCIAL OVERVIEW SNAPSHOT 74 FIGURE 21 ZOETIS: FINANCIAL OVERVIEW SNAPSHOT 77 FIGURE 22 TIANJIN RINGPU BIO-TECHNOLOGY CO., LTD: FINANCIAL OVERVIEW SNAPSHOT 81 FIGURE 23 PT JAPFA COMFEED INDONESIA TBK: FINANCIAL OVERVIEW SNAPSHOT 82 FIGURE 24 MERCK ANIMAL HEALTH: FINANCIAL OVERVIEW SNAPSHOT 85

Boehringer Ingelheim International GmbH (Germany), Guangdong Wenshi Dahuanong Biotechnology Co., Ltd (China), Ceva (US), Yebio Bioengineering Co., Ltd (China), Zoetis (US), FATRO S.P.A. (Italy), CAVAC (South Korea), Tianjin Ringpu Bio-Technology Co., Ltd (China), PT Japfa Comfeed Indonesia Tbk (Indonesia), Chengdu Tech-bank Biological Products Co., Ltd (China), Merck Animal Health (US), Medion (Indonesia), Avimex Animal Health (Mexico), JOVAC (Jordan), and QYH BIOTECH COMPANY LIMITED (China). Some of the key strategies followed by players operating in the global avian influenza vaccine market were collaborations, acquisition, product approval & launch, and expansion